{"id":"W4391792531","doi":"10.1016/j.jtocrr.2024.100645","title":"Efficacy and Safety of Dose-Escalated Alectinib in Patients With Metastatic ALK-Positive NSCLC and Central Nervous System Relapse on Standard-Dose Alectinib","year":2024,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; National Institutes of Health; Array BioPharma; Massachusetts General Hospital; Lunit; Amgen; Pfizer; Agios Pharmaceuticals; Bristol-Myers Squibb","keywords":"Alectinib; Medicine; Oncology; Crizotinib; Internal medicine; Lung cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001420252,0.000168826,0.0005542823,0.0002129385,0.0001329894,0.00005601413,0.00002530586,0.0001032394,0.00001217054],"category_scores_gemma":[0.0007619037,0.0001018758,0.00005664472,0.0004351666,0.0004206764,0.00008160734,0.00005894373,0.0005963363,0.000001087848],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001560059,"about_ca_system_score_gemma":0.0004859137,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002698583,"about_ca_topic_score_gemma":0.00006324433,"domain_scores_codex":[0.9971502,0.0003188786,0.000800539,0.000607092,0.0007517738,0.0003714717],"domain_scores_gemma":[0.9977781,0.001165801,0.0001137612,0.0002318672,0.0003349153,0.0003756046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02651755,0.00228307,0.7863891,0.001682343,0.00186536,0.009260092,0.002569657,0.00001662591,0.00004304105,0.0004312682,0.001025437,0.1679165],"study_design_scores_gemma":[0.008083154,0.005798052,0.9815238,0.002514849,0.0003033237,0.0002271701,0.000264408,0.0001057086,0.00004239431,0.0000691829,0.0009530961,0.0001149181],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994449,0.001021623,0.000008695916,0.0006354416,0.0001621745,0.001650329,0.00004821874,0.00003705324,0.001987522],"genre_scores_gemma":[0.998805,0.0003562096,0.000156643,0.0000279463,0.00004945421,0.00003312715,0.00004801608,0.0000257664,0.0004978256],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1951347,"threshold_uncertainty_score":0.4154373,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03893543307576351,"score_gpt":0.4216651979989756,"score_spread":0.382729764923212,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}